
Join to view full profile
1 Medical Center DriveLebanon, NH 03756
Phone+1 603-653-6181
Fax+1 603-727-7818
Dr. Chamberlin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mary Chamberlin, MD is an oncologist based in Lebanon, NH, with a specific focus on lifestyle interventions and clinical trials for endocrine-resistance in metastatic ER positive breast cancer and capacity-building in oncology research and education in Low- and Middle-Income Countries. She has led numerous clinical trials at Dartmouth and co-edited a special issue of Hematology/Oncology Clinics of North America on Global Oncology: Disparities, Outcomes and Innovations Around the Globe, published February 2024. Dr. Chamberlin completed her Fellowship in Hematology and Medical Oncology at Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital from 2004 to 2006, after completing her Residency in Internal Medicine at the University of Vermont Medical Center between 2000 to 2003. She is a prolific contributor to the medical field with multiple publications under her name, displaying a clear interest in cancer research and care for patients in low-income countries.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 2004 - 2006
University of Vermont Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Vermont College of MedicineClass of 2000
Certifications & Licensure
NH State Medical License 2003 - 2027
VT State Medical License 2000 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Feb 28
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Feb 08
- Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy
Publications & Presentations
PubMed
- Referral Patterns and Delays in the Care of Patients With Breast Complaints in Rwanda: A Cohort Study From a Tertiary Hospital.Vincent Kwizera, Benitha Rangira, Brandon A Niyibizi, Daniella Rangira, Diane A Ndoli
JCO Global Oncology. 2026-03-01 - Homocystinuria in a consanguineous indigenous family from rural Honduras: a ten-year follow up and literature review of familial cases.Anahita Tewari Kodali, Eduardo Rene Schrunder, Linda Skewes Kennedy, Mary D Chamberlin, César Ulises Alas Pineda
Archive of Clinical Cases. 2026-01-01 - 12 citationsOxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.Steven Tau, Mary D Chamberlin, Huijuan Yang, Jonathan D Marotti, Patricia C Muskus
Cancer Research. 2025-03-14
Press Mentions
Virginia Department of Health to Open Community Vaccination Center in Fredericksburg for Booster ShotsOctober 14th, 2021
COVID Hospitalizations Double in Stafford County in 5 DaysAugust 3rd, 2021
Northern Virginia Counties Promote Vaccines as Rates StallJuly 26th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









